UTokyo Innovation Platform Co. Ltd. — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Storm Therapeuticsstormtherapeutics.comin𝕏Apr 2026
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Co-investorsCambridge Innovation CapitalFast Track InitiativeM VenturesPfizer Venture InvestmentsSeroba Life SciencesTaiho Ventures, LLC+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.